University of Virginia team combines focused ultrasound and microRNA to target glioblastoma genes
An experimental strategy using sound waves to deliver microRNA nanoparticles into brain tumours simultaneously silences multiple cancer-driving genes in laboratory models.
Researchers at the University of Virginia have described a multi-component experimental strategy for attacking glioblastoma, the most common and aggressive primary brain tumour in adults. The approach pairs focused ultrasound — which can transiently open the blood-brain barrier — with lipid nanoparticles carrying synthetic microRNA molecules designed to suppress several pro-tumourigenic genes at once.
MicroRNAs are short non-coding RNA sequences that regulate gene expression post-transcriptionally. In cancer, certain microRNAs act as tumour suppressors, and their loss or downregulation has been documented in glioblastoma. Delivering therapeutic microRNAs into brain tissue is technically challenging because the blood-brain barrier restricts the passage of large or charged molecules; focused ultrasound in combination with microbubbles is an established research technique for transient, localised barrier opening.
The Virginia team's strategy targets multiple cancer-driving genes simultaneously, an approach intended to reduce the likelihood of resistance that can arise when single-target therapies are used. The research is at a preclinical stage; the specific microRNA sequences, target genes, animal model data, and journal of publication were not available from the feed summary alone. This is an educational summary based on public reporting; the findings do not represent a clinical treatment option at this time.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-11-01Scientists use sound waves to deliver a new attack on deadly brain cancer